in Systemic sclerosis

INFLAMMATION & FIBROSIS can be devastating

Think Totality in
Systemic sclerosis

Systemic sclerosis (SSc), also called scleroderma, is a complex autoimmune disease driven by pervasive inflammation and fibrosis, yet no single treatment addresses both of these key drivers of disease.1-3

Not an actual patient.

Systemic sclerosis: inflammation and fibrosis

SSc COMPLEXITY

Systemic sclerosis is a rare, debilitating, difficult-to-treat disease driven by inflammation and fibrosis.1,4,5

0 treatments indicated for underlying disease

TREATMENT LIMITATIONS

Today’s treatments address the clinical manifestations of SSc, not the underlying mechanisms of the disease.1,3,6-10

Hypothetical SSc patient

EMERGING
MEASURES

The paradigm in systemic sclerosis is shifting with emerging methods for disease evaluation.11

Future Hope

It's time for treatments to address the complex interplay between inflammation and fibrosis that drives systemic sclerosis.

CB1 and CB2 overlays on human body

KEEP UP
WITH CORBUS

Sign up for updates about the latest news, research, and innovations from
Corbus Pharmaceuticals.

Plants and greenery